GBAS anticorps (AA 176-210)
-
- Antigène Voir toutes GBAS Anticorps
- GBAS (Glioblastoma Amplified Sequence (GBAS))
-
Épitope
- AA 176-210
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp GBAS est non-conjugé
-
Application
- Western Blotting (WB)
- Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- Immunogène
- This GBAS antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 176-210 amino acids from the Central region of human GBAS.
- Clone
- RB50817
- Isotype
- Ig Fraction
- Top Product
- Discover our top product GBAS Anticorps primaire
-
-
- Indications d'application
- WB: 1:1000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Date de péremption
- 6 months
-
-
Mitochondrial proteins NIP-SNAP-1 and -2 are a target for the immunomodulatory activity of clarithromycin, which involves NF-κB-mediated cytokine production." dans: Biochemical and biophysical research communications, Vol. 483, Issue 3, pp. 911-916, (2017) (PubMed).
: "
-
Mitochondrial proteins NIP-SNAP-1 and -2 are a target for the immunomodulatory activity of clarithromycin, which involves NF-κB-mediated cytokine production." dans: Biochemical and biophysical research communications, Vol. 483, Issue 3, pp. 911-916, (2017) (PubMed).
-
- Antigène
- GBAS (Glioblastoma Amplified Sequence (GBAS))
- Autre désignation
- GBAS (GBAS Produits)
- Poids moléculaire
- 33743
- UniProt
- O75323
- Pathways
- Ribonucleoside Biosynthetic Process
-